Pharma Stocks Plunge Amid U.S. Price Pressure
Leading pharmaceutical companies are facing a sharp decline in their share prices as President Trump demands lower drug prices in the U.S. The Nifty Pharma index has fallen over 2.8% for three consecutive days, with Sun Pharma leading the drop. Trump’s letters to 17 major drug companies call for immediate price reductions and fair pricing for future medicines. If compliance is not met within 60 days, the U.S. may impose stricter measures. This situation raises concerns for Indian firms heavily reliant on U.S. markets, potentially affecting their revenues and pricing strategies.
